Tablets India Limited (TIL) is a renowned pharmaceutical company with a legacy of providing high-quality healthcare solutions for over eight decades. Headquartered in Chennai, India, TIL is a pioneer in developing innovative and affordable pharmaceutical products, catering to both domestic and international markets.

TIL specializes in a diverse range of therapeutic categories, including gastroenterology, pediatrics, gynecology, respiratory care, and critical care. The company is particularly recognized for its expertise in probiotics, with groundbreaking formulations that have set benchmarks in healthcare. With a focus on research and development, Tablets India consistently brings advanced and effective medicines to the market, improving the quality of life for millions.

The company’s state-of-the-art manufacturing facilities comply with global regulatory standards such as WHO-GMP, ensuring products meet the highest quality benchmarks. TIL’s robust distribution network and dedicated workforce ensure seamless delivery of healthcare solutions to customers worldwide.

Guided by a mission to advance healthcare through innovation and integrity, Tablets India Limited is committed to improving patient outcomes and addressing unmet medical needs. Through its unwavering focus on quality, research, and customer satisfaction, TIL continues to lead in the pharmaceutical industry as a trusted name in healthcare.